Mounjaro (Tirzepatide) shares many side effects with other GLP-1 medications, but as a dual GIP/GLP-1 receptor agonist, some people find the GI effects slightly different in timing and intensity.
The most common side effects:
Typical timeline:
Less common but important to know:
Managing the early weeks:
If side effects are severe or not improving after 3 to 4 weeks at the same dose, **talk to your provider** about holding at a lower dose longer before stepping up.
Different ways people phrase this question. Each expands to the same answer.
Mounjaro (Tirzepatide) shares many side effects with other GLP-1 medications, but as a dual GIP/GLP-1 receptor agonist, some people find the GI effects slightly different in timing and intensity.
The most common side effects:
Typical timeline:
Less common but important to know:
Managing the early weeks:
If side effects are severe or not improving after 3 to 4 weeks at the same dose, **talk to your provider** about holding at a lower dose longer before stepping up.
Mounjaro (Tirzepatide) shares many side effects with other GLP-1 medications, but as a dual GIP/GLP-1 receptor agonist, some people find the GI effects slightly different in timing and intensity.
The most common side effects:
Typical timeline:
Less common but important to know:
Managing the early weeks:
If side effects are severe or not improving after 3 to 4 weeks at the same dose, **talk to your provider** about holding at a lower dose longer before stepping up.
Mounjaro (Tirzepatide) shares many side effects with other GLP-1 medications, but as a dual GIP/GLP-1 receptor agonist, some people find the GI effects slightly different in timing and intensity.
The most common side effects:
Typical timeline:
Less common but important to know:
Managing the early weeks:
If side effects are severe or not improving after 3 to 4 weeks at the same dose, **talk to your provider** about holding at a lower dose longer before stepping up.